Richard D. Baird

机构：University of Cambridge, Cancer Research UK, Cambridge University Hospitals NHS Foundation Trust, Cancer Research UK Cambridge Center · ORCID：0000-0001-7071-6483

发表论文 370 篇 · 总被引 12798 次 · h-index 42

代表论文

• The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial (2025 · Clinical Cancer Research · 被引 7)
• Collaborative framework on responsible AI in LLM-driven CDSS for precision oncology leveraging real-world patient data (2025 · npj Precision Oncology · 被引 6)
• Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial (2026 · Nature Cancer · 被引 4)
• PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2− Breast Cancer: Clinical and Circulating Tumor DNA Results (2026 · Clinical Cancer Research · 被引 2)
• Abstract PD2-08: Detecting subtype switching in metastatic breast cancer with circulating tumor DNA methylation profiling (2026 · Clinical Cancer Research · 被引 1)
• ctDNA predicts radiological response to immune checkpoint inhibition for patients with advanced oesophageal adenocarcinoma: a pilot interventional phase 2 study (2026 · Communications Medicine)